Global Opioid Induced Constipation Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 681572
  • |
  • Publishe Date : 12-Nov-18
  • |
  • No of Pages: 123
  • |
  • Publisher : Global Info Research

There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over the recent past, but the continuous approval rate of highly targeted drugs is expected to provide a strong push to this market?s growth rate.

Scope of the Report:
This report studies the Opioid Induced Constipation Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Opioid Induced Constipation Treatment market by product type and applications/end industries.
The global Opioid Induced Constipation Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Opioid Induced Constipation Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Parenteral (Subcutaneous Injection)

Market Segment by Applications, can be divided into
Drug Store
Independent Pharmacies
Hospital Pharmacies

Table of Contents

1 Opioid Induced Constipation Treatment Market Overview
1.1 Product Overview and Scope of Opioid Induced Constipation Treatment
1.2 Classification of Opioid Induced Constipation Treatment by Types
1.2.1 Global Opioid Induced Constipation Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Types in 2017
1.2.3 Oral
1.2.4 Parenteral (Subcutaneous Injection)
1.3 Global Opioid Induced Constipation Treatment Market by Application
1.3.1 Global Opioid Induced Constipation Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Drug Store
1.3.3 Independent Pharmacies
1.3.4 Hospital Pharmacies
1.4 Global Opioid Induced Constipation Treatment Market by Regions
1.4.1 Global Opioid Induced Constipation Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Opioid Induced Constipation Treatment (2013-2023)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Opioid Induced Constipation Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Opioid Induced Constipation Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Opioid Induced Constipation Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 S.L.A. Pharma
2.4.1 Business Overview
2.4.2 Opioid Induced Constipation Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 AIKO Biotechnology
2.5.1 Business Overview
2.5.2 Opioid Induced Constipation Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cubist Pharmaceuticals
2.6.1 Business Overview
2.6.2 Opioid Induced Constipation Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Salix Pharmaceuticals
2.7.1 Business Overview
2.7.2 Opioid Induced Constipation Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda Pharmaceutical
2.8.1 Business Overview
2.8.2 Opioid Induced Constipation Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Opioid Induced Constipation Treatment Market Competition, by Players
3.1 Global Opioid Induced Constipation Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Opioid Induced Constipation Treatment Players Market Share
3.2.2 Top 10 Opioid Induced Constipation Treatment Players Market Share
3.3 Market Competition Trend
4 Global Opioid Induced Constipation Treatment Market Size by Regions
4.1 Global Opioid Induced Constipation Treatment Revenue and Market Share by Regions
4.2 North America Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
5 North America Opioid Induced Constipation Treatment Revenue by Countries
5.1 North America Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)
5.2 USA Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
6 Europe Opioid Induced Constipation Treatment Revenue by Countries
6.1 Europe Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)
6.2 Germany Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
6.4 France Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Opioid Induced Constipation Treatment Revenue by Countries
7.1 Asia-Pacific Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)
7.2 China Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
7.5 India Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
8 South America Opioid Induced Constipation Treatment Revenue by Countries
8.1 South America Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)
8.2 Brazil Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Opioid Induced Constipation Treatment by Countries
9.1 Middle East and Africa Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
10 Global Opioid Induced Constipation Treatment Market Segment by Type
10.1 Global Opioid Induced Constipation Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Opioid Induced Constipation Treatment Market Forecast by Type (2018-2023)
10.3 Oral Revenue Growth Rate (2013-2023)
10.4 Parenteral (Subcutaneous Injection) Revenue Growth Rate (2013-2023)
11 Global Opioid Induced Constipation Treatment Market Segment by Application
11.1 Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2013-2018)
11.2 Opioid Induced Constipation Treatment Market Forecast by Application (2018-2023)
11.3 Drug Store Revenue Growth (2013-2018)
11.4 Independent Pharmacies Revenue Growth (2013-2018)
11.5 Hospital Pharmacies Revenue Growth (2013-2018)
12 Global Opioid Induced Constipation Treatment Market Size Forecast (2018-2023)
12.1 Global Opioid Induced Constipation Treatment Market Size Forecast (2018-2023)
12.2 Global Opioid Induced Constipation Treatment Market Forecast by Regions (2018-2023)
12.3 North America Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
12.6 South America Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Opioid Induced Constipation Treatment Picture
Table Product Specifications of Opioid Induced Constipation Treatment
Table Global Opioid Induced Constipation Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Opioid Induced Constipation Treatment Revenue Market Share by Types in 2017
Figure Oral Picture
Figure Parenteral (Subcutaneous Injection) Picture
Table Global Opioid Induced Constipation Treatment Revenue (Million USD) by Application (2013-2023)
Figure Opioid Induced Constipation Treatment Revenue Market Share by Applications in 2017
Figure Drug Store Picture
Figure Independent Pharmacies Picture
Figure Hospital Pharmacies Picture
Table Global Market Opioid Induced Constipation Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Opioid Induced Constipation Treatment Type and Applications
Table GlaxoSmithKline Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Opioid Induced Constipation Treatment Type and Applications
Table AstraZeneca Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Opioid Induced Constipation Treatment Type and Applications
Table Pfizer Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table S.L.A. Pharma Basic Information, Manufacturing Base and Competitors
Table S.L.A. Pharma Opioid Induced Constipation Treatment Type and Applications
Table S.L.A. Pharma Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AIKO Biotechnology Basic Information, Manufacturing Base and Competitors
Table AIKO Biotechnology Opioid Induced Constipation Treatment Type and Applications
Table AIKO Biotechnology Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Cubist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cubist Pharmaceuticals Opioid Induced Constipation Treatment Type and Applications
Table Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Salix Pharmaceuticals Opioid Induced Constipation Treatment Type and Applications
Table Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Opioid Induced Constipation Treatment Type and Applications
Table Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Opioid Induced Constipation Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Opioid Induced Constipation Treatment Revenue Share by Players (2013-2018)
Figure Global Opioid Induced Constipation Treatment Revenue Share by Players in 2016
Figure Global Opioid Induced Constipation Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Opioid Induced Constipation Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Opioid Induced Constipation Treatment Revenue Market Share in 2017
Figure Global Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Opioid Induced Constipation Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Opioid Induced Constipation Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Opioid Induced Constipation Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Opioid Induced Constipation Treatment Revenue Market Share by Regions in 2017
Figure North America Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure South America Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Table North America Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)
Table North America Opioid Induced Constipation Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Opioid Induced Constipation Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2017
Figure USA Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Table Europe Opioid Induced Constipation Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Opioid Induced Constipation Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2017
Figure Germany Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure UK Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure France Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Opioid Induced Constipation Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2017
Figure China Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure India Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Table South America Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)
Table South America Opioid Induced Constipation Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Opioid Induced Constipation Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2017
Figure Brazil Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Opioid Induced Constipation Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)
Table Global Opioid Induced Constipation Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Opioid Induced Constipation Treatment Revenue Share by Type (2013-2018)
Figure Global Opioid Induced Constipation Treatment Revenue Share by Type (2013-2018)
Figure Global Opioid Induced Constipation Treatment Revenue Share by Type in 2017
Table Global Opioid Induced Constipation Treatment Revenue Forecast by Type (2018-2023)
Figure Global Opioid Induced Constipation Treatment Market Share Forecast by Type (2018-2023)
Figure Global Oral Revenue Growth Rate (2013-2018)
Figure Global Parenteral (Subcutaneous Injection) Revenue Growth Rate (2013-2018)
Table Global Opioid Induced Constipation Treatment Revenue by Application (2013-2018)
Table Global Opioid Induced Constipation Treatment Revenue Share by Application (2013-2018)
Figure Global Opioid Induced Constipation Treatment Revenue Share by Application (2013-2018)
Figure Global Opioid Induced Constipation Treatment Revenue Share by Application in 2017
Table Global Opioid Induced Constipation Treatment Revenue Forecast by Application (2018-2023)
Figure Global Opioid Induced Constipation Treatment Market Share Forecast by Application (2018-2023)
Figure Global Drug Store Revenue Growth Rate (2013-2018)
Figure Global Independent Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Opioid Induced Constipation Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Opioid Induced Constipation Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
Figure Europe Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
Figure South America Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)

Choose License Type